US2004077038A1PendingUtilityA1
Methods for production of proteins in host cells
Priority: Dec 23, 1999Filed: Nov 13, 2003Published: Apr 22, 2004
Est. expiryDec 23, 2019(expired)· nominal 20-yr term from priority
C12N 15/70
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides methods for the production of proteins, particularly toxic proteins, in host cells. The invention provides methods which use a fusion protein comprising a chaperonin binding domain in host cells induced or regulated to have increased levels of chaperonin which binds the chaperonin binding domain.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A method for producing a protein in a host cell, comprising the step of culturing a host cell comprising a first nucleic acid encoding an isolated chaperonin binding domain associated with a second nucleic acid encoding the protein and a third nucleic acid encoding a chaperonin, under conditions suitable for expression of said first, said second and said third nucleic acid and wherein said chaperonin binding domain is capable of binding to said chaperonin.
2 . The method of claim 1 further comprising recovering said protein from said cell.
3 . The method of claim 1 wherein said nucleic acid encoding the chaperonin is naturally produced by the host cell.
4 . The method of claim 3 wherein said cell is grown under conditions that result in elevation of the levels of the naturally produced chaperonin.
5 . The method of claim 1 wherein said nucleic acid encoding the chaperonin is heterologous to the host cell.
6 . The method of claim 1 wherein said host cell is a bacterial cell.
7 . The method of claim 6 wherein said bacterial cell is a member of the family Enterobacteriaceae
8 . The method of claim 7 wherein said bacterial cell is E. coli.
9 . The method of claim 1 wherein the chaperonin binding domain has a sequence as shown in SEQ ID NO: 1 through SEQ ID NO: 38.
10 . The method of claim 1 wherein said chaperonin binding domain is obtainable from GroES and said chaperonin is the GroEL chaperonin.
11 . The method of claim 10 wherein the chaperonin binding domain comprises the amino acid sequence EVETKSAGGIVLTGSAAA or is a variation thereof capable of binding to GroEL chaperonin with an affinity of between about 10 −2 and 10 −8 Kd.
12 . The method of claim 1 wherein said first and said second nucleic acid encode a fusion protein.
13 . The method of claim 12 wherein said first and said second nucleic acid encode a fusion protein and are separated by an enzymatic cleavage site.
14 . The method of claim 12 wherein said first and said second nucleic acid encode a fusion protein and are separated by a chemical cleavage site.
15 . The method of claim 1 wherein said protein is toxic to the host cell.
16 . The method of claim 5 wherein said chaperonin heterologous to the host cell is under the control of an expression signal capable of overexpression said chaperonin.
17 . An expression vector comprising a first nucleic acid encoding a chaperonin binding domain and a second nucleic acid encoding a protein.
18 . The expression vector of claim 17 wherein the chaperonin binding domain has a sequence as shown in SEQ ID NO: 1 through SEQ ID NO: 38
19 . The expression vector of claim 18 wherein the chaperonin binding domain is obtainable from GroES.
20 . The expression vector of claim 18 wherein the chaperonin binding domain comprises the amino acid sequence EVETKSAGGIVLTGSAAA or a variation thereof capable of binding to GroEL chaperonin with an affinity of between about 10 −2 and 10 −8 Kd.
21 . A host cell containing the expression vector of claim 17 .
22 . The host cell of claim 21 wherein the host cell is a member of the family Enterobacteriaceae.
23 . The host cell of claim 22 wherein the host cell is E. coli.Join the waitlist — get patent alerts
Track US2004077038A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.